The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.
Pennant Group Inc (NASDAQ:PNTG)
- On Nov. 4, The Pennant Group reported worse-than-expected third-quarter adjusted EPS results. “Pennant delivered a solid quarter and strong year-over-year improvement across the organization,” said Brent Guerisoli, the Company’s Chief Executive Officer. The company’s stock fell around 18% over the past month and has a 52-week low of $25.56.
- RSI Value: 29.8
- PNTG Price Action: Shares of Pennant fell 4.8% to close at $34.09 on Thursday.
- Edge Stock Ratings: 77.33 Momentum score with Value at 25.41.

Iovance Biotherapeutics Inc (NASDAQ:IOVA)
- On Nov. 5, Iovance Biotherapeutics posted better-than-expected earnings for the third quarter. “Third quarter revenue reached a new record of ~$122 million with our highest gross margin ever, driven by continued U.S. Amtagvi demand,” said Frederick Vogt, Ph.D., J.D., Interim Chief Executive Officer and President. The company’s stock fell around 51% over the past month and has a 52-week low of $2.08.
- RSI Value: 29.8
- IOVA Price Action: Shares of Iovance Biotherapeutics fell 2.3% to close at $7.31 on Thursday.
- Benzinga Pro’s charting tool helped identify the trend in IOVA stock.

BillionToOne Inc (NASDAQ:BLLN)
- On Nov. 18, Fuzzy Panda Research issued a critical report on the company and disclosed a short position. The short seller alleged undisclosed Medicaid billing irregularities, illegal kickbacks, flaws in oncology diagnostics and unreported test failures. The company’s stock fell around 19% over the past five days and has a 52-week low of $61.96.
- RSI Value: 29.9
- BLLN Price Action: Shares of BillionToOne fell 1.5% to close at $90.20 on Thursday.
- Benzinga Pro’s signals feature notified of a potential breakout in BLLN shares.

BZ Edge Rankings: Find out where other stocks stand—explore the full comparison now.
Photo via Shutterstock
Recent Comments